Diabetes, Vol 40, Issue 5 568-573, Copyright © 1991 by American Diabetes Association

ARTICLES

In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle

S Frontoni, SB Choi, D Banduch and L Rossetti
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7886.

We examined the in vivo mechanisms of amylin-induced resistance in concious rats (n = 18). During 180-min euglycemic insulin-clamp (21.5 pmol.kg-1.min-1) studies, amylin (50, 200, or 500 pmol.kg-1.min-1; plasma concentration from 3 x 10(-10) to 9 x 10(-9) M) infusion determined a 19-27% reduction in glucose uptake (117.8 +/- 7.0 vs. 145.8 +/- 11.0, 107.1 +/- 9.2 vs. 145.1 +/- 6.7, and 105.0 +/- 7.2 vs. 144.4 +/- 7.0 mumol.kg-1.min-1 at 50, 200, or 500 pmol.kg-1.min-1, respectively, P less than 0.01) versus insulin alone, whereas 10-pmol.kg-1.min-1 amylin infusion (plasma concn 5 x 10(-11) M) failed to affect insulin-mediated glucose disposal. After amylin infusion, the contribution of whole-body glycolysis to overall glucose disposal increased from 43-48 to 62-79%, whereas muscle glycogen synthesis decreased significantly at all peptide concentrations greater than 3 x 10(-10) M, completely accounting for the decrease in glucose uptake. Skeletal muscle glucose-6-phosphate concentration rose from 0.219 +/- 0.038 mumol/g (insulin alone) to 0.350 +/- 0.018, 0.440 +/- 0.020, and 0.505 +/- 0.035 mumol/g (insulin plus amylin at 50, 200, or 500 pmol.kg-1.min-1, P less than 0.01). Suppression of hepatic glucose production by insulin was unaffected by a 50-pmol.kg-1.min-1 amylin infusion (18.5 +/- 4.3 vs. 21.7 +/- 2.9 mumol.kg-1.min-1), whereas it was slightly but significantly impaired by amylin infusion at 200 pmol.kg-1.min-1 (17.8 +/- 3.9 vs. 24.7 +/- 4.5 mumol.kg-1.min-1, P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Knauf, P. D. Cani, A. Ait-Belgnaoui, A. Benani, C. Dray, C. Cabou, A. Colom, M. Uldry, S. Rastrelli, E. Sabatier, et al. Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure Endocrinology, October 1, 2008; 149(10): 4768 - 4777. [Abstract] [Full Text] [PDF]

				R. C. Noland, J. P. Thyfault, S. T. Henes, B. R. Whitfield, T. L. Woodlief, J. R. Evans, J. A. Lust, S. L. Britton, L. G. Koch, R. W. Dudek, et al. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E31 - E41. [Abstract] [Full Text] [PDF]

				S. B. Choi, J. S. Jang, S. M. Hong, D. W. Jun, and S. Park Exercise and dexamethasone oppositely modulate {beta}-cell function and survival via independent pathways in 90% pancreatectomized rats. J. Endocrinol., August 1, 2006; 190(2): 471 - 482. [Abstract] [Full Text] [PDF]

				S. B. Choi, J. S. Jang, and S. Park Estrogen and Exercise May Enhance {beta}-Cell Function and Mass via Insulin Receptor Substrate 2 Induction in Ovariectomized Diabetic Rats Endocrinology, November 1, 2005; 146(11): 4786 - 4794. [Abstract] [Full Text] [PDF]

				Y. Wang, A. Xu, J. Ye, E. W. Kraegen, C. A. Tse, and G. J.S. Cooper Alteration in Phosphorylation of P20 Is Associated With Insulin Resistance Diabetes, August 1, 2001; 50(8): 1821 - 1827. [Abstract] [Full Text] [PDF]

				H. Mulder, S. Gebre-Medhin, C. Betsholtz, F. Sundler, and B. Ahren Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E684 - E691. [Abstract] [Full Text] [PDF]

				A. L. Castle, C.-H. Kuo, D.-H. Han, and J. L. Ivy Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E531 - E536. [Abstract] [Full Text] [PDF]

				A. L. Castle, C.-H. Kuo, and J. L. Ivy Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E6 - E12. [Abstract] [Full Text] [PDF]

				U. Arnelo, J. Permert, J. Larsson, R. D. Reidelberger, C. Arnelo, and T. E. Adrian Chronic Low Dose Islet Amyloid Polypeptide Infusion Reduces Food Intake, But Does Not Influence Glucose Metabolism, in Unrestrained Conscious Rats: Studies Using a Novel Aortic Catheterization Technique Endocrinology, October 1, 1997; 138(10): 4081 - 4085. [Abstract] [Full Text] [PDF]

				J. E. Dimsdale, O. Kolterman, J. Koda, and R. Nelesen Effect of Race and Hypertension on Plasma Amylin Concentrations Hypertension, June 1, 1996; 27(6): 1273 - 1276. [Abstract] [Full Text]